140 related articles for article (PubMed ID: 1144761)
1. Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors.
Hazra TA; Parks LC; Inalsingh A; Peeples W
Radiology; 1975 May; 115(2):429-30. PubMed ID: 1144761
[TBL] [Abstract][Full Text] [Related]
2. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
Bolton PM
Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
[No Abstract] [Full Text] [Related]
3. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
[TBL] [Abstract][Full Text] [Related]
4. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
Ruszel KB
Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
[No Abstract] [Full Text] [Related]
5. The delayed hypersensitivity reaction in cancer patient: observations on sensitization by DNCB.
Chakravorty RC; Curutchet HP; Coppolla FS; Park CM; Blaylock WK; Lawrence W
Surgery; 1973 May; 73(5):730-5. PubMed ID: 4697093
[No Abstract] [Full Text] [Related]
6. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
Osoba D; Kersey PA; Clark RM; Rosen IB
Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
[TBL] [Abstract][Full Text] [Related]
7. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
Maisel RH; Ogura JH
Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
[TBL] [Abstract][Full Text] [Related]
8. Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival.
Bosworth JL; Ghossein NA; Brooks TL
Cancer; 1975 Aug; 36(2):353-8. PubMed ID: 1157006
[TBL] [Abstract][Full Text] [Related]
9. A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer.
Cunningham TJ; Daut D; Wolfgang PE; Mellyn M; Maciolek S; Sponzo RW; Horton J
Cancer; 1976 Apr; 37(4):1696-1700. PubMed ID: 1260685
[TBL] [Abstract][Full Text] [Related]
10. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
[TBL] [Abstract][Full Text] [Related]
11. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
Inoue H; Ishihara T; Kobayashi K; Fukai S
J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva.
Ferry AP; Meltzer MA; Taub RN
Trans Am Ophthalmol Soc; 1976; 74():154-71. PubMed ID: 325854
[TBL] [Abstract][Full Text] [Related]
14. Delayed hypersensitivity in patients with bronchial carcinoma.
Pauwels R; van der Straeten M
Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
[TBL] [Abstract][Full Text] [Related]
15. Qualitative DNCB skin test in cancer patients.
Dutta TK; Sengputa U; Gupta BD
Indian J Cancer; 1977 Dec; 14(4):351-3. PubMed ID: 612559
[No Abstract] [Full Text] [Related]
16. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
Obalek S; Haftek M; Sliński W
Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
[TBL] [Abstract][Full Text] [Related]
17. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
Lee YT; Sparks FC; Eilber FR; Morton DL
Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
[TBL] [Abstract][Full Text] [Related]
18. DNCB reactivity and prognosis in 419 patients with malignant melanoma.
Camacho ES; Pinsky CM; Braun DW; Golbey RB; Fortner JG; Wanebo HJ; Oettgen HF
Cancer; 1981 May; 47(10):2446-50. PubMed ID: 7272900
[TBL] [Abstract][Full Text] [Related]
19. Quantitative dinitrochlorobenzene contact sensitivity in preoperative and cured cancer patients.
Chretien PB; Twomey PL; Trahan EE; Catalona WJ
Natl Cancer Inst Monogr; 1973 Dec; 39():263-6. PubMed ID: 4787068
[No Abstract] [Full Text] [Related]
20. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
Djawari D; Körner E; Haneke E
Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
